Articles tagged with Translational Research
A new complex-carbohydrate biomolecule has been identified as crucial for Bordetella bacteria to colonize the nose and transmit to a new host. The discovery opens up possibilities for creating a new drug or vaccine that interferes with this glycan, potentially eliminating whooping cough transmission.
Researchers discover how S1P molecules are released from SPNS2 protein via small cavities, enabling potential treatment for inflammatory diseases. The study provides a foundation for designing future drugs targeting the protein.
A new special issue of Calcified Tissue International & Musculoskeletal Research sheds light on sarcopenia's pathogenesis, clinical implications, and therapeutic targets. Researchers have made significant progress in evaluating, managing, and developing interventions for this condition.
Researchers develop injectable hydrogel electrodes for treating ventricular arrhythmia, providing a potential solution to painful defibrillation and improving quality of life. The novel pacing modality addresses the pathophysiology of re-entrant arrhythmia and offers a promising alternative to existing therapies.
Researchers found that specific microbes in the gut reduce graft versus host disease after stem cell transplantation. Patients with low microbial metabolite risk index had better survival rates, fewer graft vs. host reactions, and reduced relapses.
Binghamton University will receive $6 million from the NSF to translate cutting-edge research into real-world applications and promote regional entrepreneurship. The initiative aims to increase the university's capacity for translational research, providing students with practical training and career development opportunities.
A team of University of Maryland researchers developed a nasal spray vaccine that delivers the SARS-CoV-2 spike protein into cells of the airway, triggering an immune response that significantly reduced infection and spread of COVID-19. The technology can be adapted to induce immunity to other respiratory illnesses.
A pioneering collection of brain metastasis living samples has been established, enabling researchers to study the response to specific drugs and identify the best therapeutic options for each patient. The RENACER network connects hospitals and patients, facilitating the rapid sharing of research findings and clinical trial data.
The Cumming Global Centre for Pandemic Therapeutics is offering global grants of up to $200,000 per annum for three years to develop novel therapeutics for pathogens of pandemic potential. Researchers are invited to submit expressions of interest for Round Two of the Foundation Grants program.
The NYSCF – Robertson Stem Cell Investigator Awards support promising early career scientists with cutting-edge research, providing $1.5 million over five years for seed funding. The latest cohort includes three talented researchers who will join the thirteenth class of NYSCF – Robertson Stem Cell Investigators.
A recent NIH grant will support research into the genetic factors contributing to cardiac arrhythmia, a condition affecting millions of Americans. The study aims to identify specific genes linked to arrhythmia risk and develop novel therapeutic approaches.
A University of Melbourne research team is developing an oral therapeutic to restore the activity of common antibiotics used to treat community-acquired bacterial pneumonia. The project aims to combat antibiotic-resistant bacteria and reduce healthcare costs, with potential applications in low- and middle-income countries.
Veterinary researchers used 3D organoids to investigate lung cancer in dogs, finding that canine primary lung cancer organoids faithfully mirrored tumor tissues. The study identified correlations between organoid cell viability and specific target molecules, paving the way for personalized treatment approaches.
Researchers propose that cerebrospinal fluid leaks could contribute to the link between traumatic brain injury and dementia. The hypothesis suggests that treating these leaks could mitigate dementia symptoms in some patients with a history of TBI. Further research is needed to confirm this potential association.
The South Carolina Clinical and Translational Research Institute's program provides early-career clinicians with the time and training needed to establish a sustainable portfolio of clinical trials. Scholars attend 'meet the expert' presentations, discuss strategies with mentors, and select suitable trials.
Researchers found that rodents exposed to light for the first time in adulthood showed significant plasticity in their brains, challenging previous beliefs about adult brain rigidity. After a month, their brains looked similar to those of healthy controls, with organized visual responses and smaller receptive fields.
Researchers at the University of Missouri have developed a new type of nanoclay material that can be customized to perform specific tasks. This breakthrough could lead to advances in fields such as medical science, environmental science, and more.
Rice University engineers developed a low-cost, point-of-care DNA test for HPV infections that can be used to screen for cervical cancer. The test, which requires just two pieces of equipment and delivers results in 45 minutes, has the potential to make cervical cancer screening more accessible in low- and middle-income countries.
An Australian interview study suggests that advance research directives (ARD) can facilitate informed consent for people with dementia. The study also highlights the importance of family members as proxy decision-makers. In another article, a competency framework is proposed to improve health research ethics education.
Researchers used unbiased genetic screening to identify genes involved in regulating sleep in worms, finding that proteins play a crucial role. These findings suggest new approaches for preventing diseases related to sleep disturbances and inflammation.
A new partnership between Patrick Reed and Kenneth Eilertsen is putting a focus on translational research and commercialization at Pennington Biomedical. The team aims to evaluate patentability and marketability of potential disclosures, promoting public benefit from scientific discoveries.
Dr. Carol Feghali-Bostwick received an award for contributing to the diversity and inclusiveness of the translational workforce, while Dr. ReJoyce Green was recognized with the Outstanding Trainee: Post-Doctoral Award for her high productivity and impact in public health.
Researchers at Cedars-Sinai Medical Center identified a genetic variant associated with increased risk of developing perianal Crohn's disease, a debilitating manifestation of Crohn's disease. The study highlights the importance of targeting the alternative complement pathway and Complement Factor B (CFB) in treating this condition.
Researchers used a novel brain imaging technique to visualize subtle brain changes in pre-symptomatic Alzheimer's patients. They found that individualized brain fingerprints can detect variations in brain function associated with worsening information processing.
The Albert Einstein College of Medicine and Montefiore Health System have received a seven-year, $30 million grant from the National Institutes of Health to continue supporting the Harold and Muriel Block Institute for Clinical and Translational Research. The grant will advance translational science and health equity by accelerating th...
A multicenter study found that patients with cystic fibrosis can safely take a dual combination of CF modulator drugs for four years while maintaining previously achieved clinical improvement. This breakthrough therapy has improved the quality and length of patients' lives, with some even seeing a 15% increase in lung function.
Researchers developed a deep learning-based AI model to automate cirrhosis identification using large amounts of data from EHRs. The model successfully identified patients with cirrhosis with a precision of 97%, offering potential for early diagnosis and improved management of the disease.
Researchers have developed a new imaging approach to diagnose advanced non-alcoholic fatty liver disease (NASH). The enzyme-sensitive nanoprobe emits signals that can be detected by MRI techniques, providing more accurate and sensitive data for diagnosis. This breakthrough aims to improve the treatment outcomes of NASH patients.
A new cell therapy has demonstrated significant benefits in improving the heart's pumping ability and reducing the risk of cardiovascular death, heart attack, or stroke in patients with chronic heart failure. The therapy, using mesenchymal precursor cells (MPCs), also showed a strong signal in reducing inflammation and improving microv...
Researchers found that a pro-oxidant mixture of resveratrol and copper can inactivate cell-free chromatin particles, reducing chemotherapy toxicity. The treatment also showed promise in preventing aging and sepsis.
Dr. Keith Chan joins Houston Methodist to enhance chemoimmunotherapy responses in bladder cancer, while also expanding research into pancreatic and skin cancers. He will lead translational research and mentor next-generation cancer researchers.
The NSF is seeking proposals to utilize the ISS National Laboratory for fundamental research in fluid dynamics, thermal transport, and combustion. Researchers aim to advance knowledge that benefits life on Earth, particularly in predicting and preventing catastrophic mudslides after wildfires.
Researchers at UNIGE and LMU discovered that immune system's anti-tumour activity peaks in the morning. Tumours implanted at night grew faster than those implanted in the afternoon. Administering immunotherapy treatments early morning significantly enhanced their effectiveness, suggesting a new strategy for cancer treatment.
The West Texas Pharmacology Core laboratory at TTUHSC will focus on two primary areas: drug development and pediatric cancer. The core aims to address obstacles in drug development, including limited pharmacology expertise for small biotech companies and low profitability for pediatric cancer drugs.
Researchers developed a machine learning model to quickly recognize predictive risk factors and their importance for undesirable hospitalization outcomes. The model achieved an accuracy of 95.6% and identified modifiable risk factors that can be mitigated through clinical interventions.
Researchers at UMC Utrecht will investigate how intestinal microbiota impacts cancer immunotherapy and therapy side effects. The project aims to develop microbiota-targeted therapies to improve ICI treatment effectiveness and reduce severe inflammation.
Researchers at LSU Health New Orleans have identified a critical immunosuppressive pathway and developed an experimental inhibitor to protect T-cells from weakening. The CBL-B inhibitors show great potential in enhancing the efficacy of cancer immunotherapy, making patients' T-cells more effective in killing cancer cells.
The University of Cincinnati is conducting a study on a potential new treatment for pancreatic cancer using SapC-DOPG, a nanotechnology drug delivery system. The treatment has shown promise in reducing tumor growth by 50-80% in animal models and aims to develop an effective immunotherapy treatment.
A new software program, Mistic, allows for the simultaneous viewing of tissue images through dimensionality reduction methods. The software enables the extraction of data from multiplexed images, facilitating the understanding of cancer biology and the development of new therapies.
Researchers found that CXCL9 levels were higher in pre-fracture blood samples of Chinese men with subsequent hip fractures, improving the prediction of osteoporotic hip fracture risk in men. In contrast, no association was found between CXCL10 and hip fracture risk in either gender.
A new gene therapy for sickle cell disease was tested in mice but proved ineffective due to the complex genetic make-up of the Berkeley mice. The study suggests that researchers should carefully consider the genetics of the mice used to test human diseases.
The integrated tool allows tracking of clinical trial enrollment and cost effectiveness, enabling study teams to ensure trials are the best fit for the enterprise. It also enables standardization of data collection and reporting, giving the institution a competitive edge.
The UK's Joint Committee on Vaccination and Immunisation advises that COVID vaccines should be offered to 5–11-year-old children, but deem immunization as non-essential. Dr Hamid Merchant explains why current vaccines are not suitable for children due to efficacy and safety concerns.
A team of researchers has successfully treated damaged pig hearts with cardiac progenitor cells, demonstrating the formation of new cardiac tissue and improved cardiac function. The treatment could potentially be used to treat patients with serious heart failure, particularly older patients with coexisting conditions.
Researchers discovered a link between traumatic brain injuries and changes in the gut microbiome, suggesting a potential diagnostic tool for concussions. The study found two bacterial species that dropped significantly after concussions, indicating a correlation with traumatic brain injury-linked proteins in the blood.
Researchers at the University of Oxford have demonstrated the efficacy of adalimumab in treating early-stage Dupuytren's disease. The trial found that patients receiving adalimumab experienced softening and reduction in size of treated nodules, with sustained effects up to nine months after treatment.
The ESMO Breast Cancer Congress 2022 event will present more than 200 studies on various aspects of breast cancer, including new treatments and innovative clinical practices. The congress will be held onsite in Berlin, Germany, and online, offering a platform for breast cancer specialists to share knowledge and improve patient outcomes.
Researchers at Boston University have developed optoacoustic neurostimulation with single neuron and subcellular level precision. Optoacoustic neuromodulation may offer advantages over ultrasonic neuromodulation, including higher spatial temporal resolution.
The Tufts Clinical and Translational Science Institute has published a comprehensive resource on broadly engaged team science, which aims to include stakeholders in the research process. The book features perspectives and best practices from over 60 experts to inspire researchers and stakeholders to build diverse, inclusive teams.
Researchers discover a genetic mechanism linking ALS and dementia to UNC13A protein corruption, providing hope for new treatments by blocking corrupted instructions. The study found that genetic variants increase the risk of UNC13A mRNA corruption in patients with ALS and FTD.
Researchers found that it took nearly three years for these drugs and biologics to be incorporated into clinical guidelines, highlighting a significant delay in patient access. The study suggests that expedited approval processes are only the first step, and planning ahead is crucial to bring needed treatments to patients.
The University of South Florida has received a five-year, $1.35 million NIH institutional grant to train scientists in vascular inflammation and injury research. The grant will support the comprehensive training of pre- and postdoctoral scientists focused on this emerging area of research.
Researchers detect four cryptic variants of SARS-CoV-2 in NYC wastewater samples, suggesting possible animal origins. The variants' mutations could help identify the next variant of concern for COVID-19.
Researchers at Medical University of South Carolina and Clemson University published a roadmap for rolling out COVID-19 risk mitigation initiatives in educational institutions. The roadmap outlines a theory-based framework for evaluating the success of exposure notification mobile apps, which can help institutions hit the ground running.
The WV Clinical and Translational Science Institute is leading a national study on post-acute sequelae of COVID-19 (PASC) among adults. The study, funded by the National Institutes of Health, aims to better understand the long-term effects of COVID-19 and develop effective treatments for this disabling complication.
The Medical University of South Carolina's Boeing Center for Children's Wellness offers a menu of wellness initiative options that schools can tailor to their needs. Schools with health professionals on the wellness committee implement 25% more initiatives, leading to a culture change and increased student participation.
A study by the CDC found a strong association between obesity and diabetes, both of which are widespread in the U.S., and severe COVID-19 disease. In South Carolina, chronic diseases disproportionately affect Black communities, increasing their risk of developing severe COVID-19.
The WVCTSI will deploy a mobile clinical trials unit in West Virginia, addressing health disparities and increasing participation in clinical research. The 39-foot Winnebago will provide on-site clinical trials and follow-up visits to rural residents.
Researchers used sound processing to examine neural synchrony in comatose patients. They found that higher neural synchrony was predictive of a favorable outcome, with indistinguishable levels from healthy controls. The study also revealed surprising neural complexity, with reduced complexity in survivors compared to non-survivors.
Mount Sinai joins a nationwide network of medical centers specializing in rare disorders to foster knowledge-sharing, connect patients with specialists, and improve treatment and research. The designation aims to establish a standard of care for rare diseases.